Most Clicked StoriesMore >


Sanofi gains FDA approval for diabetes drug

BIO SmartBrief | Feb 26, 2015

Sanofi received federal approval for its long-acting basal insulin Toujeo for the treatment of patients with type 1 or type 2 diabetes. Reuters (02/25)


Bristol boosts cancer-drug pipeline with $1.25B Flexus buy

BIO SmartBrief | Feb 24, 2015

BIO report: Funding dwindles for new drugs to treat common diseases

BIO SmartBrief | Feb 27, 2015

Meritage Pharma bought by Shire in deal worth up to $245M

BIO SmartBrief | Feb 25, 2015

Valeant boosts GI drug portfolio with $14.5B Salix buy

BIO SmartBrief | Feb 23, 2015

Antibiotic from Forest Pharmaceuticals gets FDA nod

BIO SmartBrief | Feb 26, 2015

FDA grants breakthrough status to brain cancer drug from Celldex

BIO SmartBrief | Feb 24, 2015

Sale of GSK's oncology drugs to Novartis approved by FTC

BIO SmartBrief | Feb 24, 2015

FDA to expedite review of Pfizer drug for lung disease

BIO SmartBrief | Feb 23, 2015

Bristol-Myers signs cancer-immunotherapy-development pact with Rigel

BIO SmartBrief | Feb 25, 2015


Find BIO SmartBrief Issues by Date:



BIO News More >


Registration is open for the BIO Asia International Conference!

BIO SmartBrief | Feb 27, 2015

Industrial biotechnology with a French twist!

BIO SmartBrief | Feb 26, 2015

Savings on environmental waste disposal services

BIO SmartBrief | Feb 25, 2015

Fall 2014 BIO Therapeutic Newsletters

BIO SmartBrief | Feb 23, 2015

New BIO Survey Tool: FDA/Sponsor Interactions During Drug Development

BIO SmartBrief | Feb 16, 2015




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more